Fresh Frozen Plasma versus Crystalloid Priming of Cardiopulmonary Bypass Circuit in Pediatric Surgery
Authors:
- 1 January 2020
- journal article
- conference paper
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 132 (1) , 95-106
Abstract
Editor’s Perspective: What We Already Know about This Topic: What This Article Tells Us That Is New: Background: In congenital cardiac surgery, priming cardiopulmonary bypass (CPB) with fresh frozen plasma (FFP) is performed to prevent coagulation abnormalities. The hypothesis was that CPB priming with crystalloids would be different compared with FFP in terms of bleeding and/or need for blood product transfusion. Methods: In this parallel-arm double-blinded study, patients weighing between 7 and 15 kg were randomly assigned to a CPB priming with 15 ml · kg−1 PlasmaLyte or 15 ml · kg−1 FFP in addition to a predefined amount of packed red blood cells used in all patients. The decision to transfuse was clinical and guided by point-of-care tests. The primary endpoints included postoperative bleeding tracked by chest tubes, number of patients transfused with any additional blood products, and the total number of additional blood products administered intra- and postoperatively. The postoperative period included the first 6 h after intensive care unit arrival. Results: Respectively, 30 and 29 patients in the FFP and in the crystalloid group were analyzed in an intention-to-treat basis. Median postoperative blood loss was 7.1 ml · kg−1 (5.1, 9.4) in the FFP group and 5.7 ml · kg−1 (3.8, 8.5) in the crystalloid group (P = 0.219); difference (95% CI): 1.2 (−0.7 to 3.2). The proportion of patients additionally transfused was 26.7% (8 of 30) and 37.9% (11 of 29) in the FFP and the crystalloid groups, respectively (P = 0.355; odds ratio [95% CI], 1.7 [0.6 to 5.1]). The median number of any blood products transfused in addition to priming was 0 (0, 1) and 0 (0, 2) in the FFP and crystalloid groups, respectively (P = 0.254; difference [95% CI], 0 [0 to 0]). There were no study-related adverse events. Conclusions: The results demonstrate that in infants and children, priming CPB with crystalloids does not result in a different risk of postoperative bleeding and need for transfusion of allogeneic blood products.Keywords
This publication has 31 references indexed in Scilit:
- Human albumin in extracorporeal prime: effect on platelet function and bleedingPerfusion, 2013
- Fresh Frozen Plasma in Pump Priming for Congenital Heart Surgery: Evaluation of Effects on Postoperative Coagulation Profiles Using a Fibrinogen Assay and Rotational ThromboelastometryYonsei Medical Journal, 2013
- Widespread Use of Fresh Frozen Plasma in US Children’s Hospitals Despite Limited Evidence Demonstrating a Beneficial EffectThe Journal of Pediatrics, 2012
- Incidence and Risk Factors for Venous Thromboembolism in Critically Ill Children With Cardiac DiseasePediatric Cardiology, 2011
- Intraoperative Thromboelastometry Is Associated with Reduced Transfusion Prevalence in Pediatric Cardiac SurgeryAnesthesia & Analgesia, 2011
- High colloid oncotic pressure priming of cardiopulmonary bypass in neonates and infants: implications on haemofiltration, weight gain and renal functionEuropean Journal of Cardio-Thoracic Surgery, 2008
- Fresh frozen plasma in the pediatric pump prime: a prospective, randomized trialThe Annals of Thoracic Surgery, 2004
- Albumin versus crystalloid prime solution for cardiopulmonary bypass in young childrenCritical Care Medicine, 2002
- Coagulation defects in neonates during cardiopulmonary bypassThe Annals of Thoracic Surgery, 1992
- On the inhibitory effect of albumin on platelet aggregationThrombosis Research, 1980